Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Vimseltinib by Deciphera Pharmaceuticals for Tenosynovial Giant Cell Tumor: Likelihood of Approval
Vimseltinib is under clinical development by Deciphera Pharmaceuticals and currently in Pre-Registration for Tenosynovial Giant Cell Tumor. According to GlobalData,...
Risk adjusted net present value: What is the current valuation of Ono Pharmaceutical's Vimseltinib?
Vimseltinib is a small molecule commercialized by Ono Pharmaceutical, with a leading Pre-Registration program in Tenosynovial Giant Cell Tumor. According...
Risk adjusted net present value: What is the current valuation of Deciphera Pharmaceuticals's Vimseltinib?
Vimseltinib is a small molecule commercialized by Deciphera Pharmaceuticals, with a leading Phase III program in Tenosynovial Giant Cell Tumor....